Mueller T, Davis P L, Roberts E F. "Method for the Synthesis of (3-Aminopiperidin-1-yl)(1H-imidazol-5-yl)methanone" [P]. US Patent, US 11011779 B2, 2015-10-18.
发明人冯建国,马晓峰,沈红梅. "A Process for Preparing High-Purity (3-Aminopiperidin-1-yl)(1H-imidazol-5-yl)methanone" [P]. 中国发明专利, 专利号 CN 116946945 A, 授权公告日 2020-07-25.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 1236, (11), 7031-7044.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2022, 1501, 7291-7298.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (3-Aminopiperidin-1-yl)(1H-imidazol-5-yl)methanone Using HRMS and NMR". J. Sep. Sci., 2015, 2056, (11), 1591-1594.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 1808, (11), 4038-4044.